Patents by Inventor Carlo A. Maggi

Carlo A. Maggi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080090795
    Abstract: Pharmaceutical compositions containing NK2 antagonists are described, useful for the treatment of infantile colics.
    Type: Application
    Filed: October 26, 2005
    Publication date: April 17, 2008
    Applicant: LABORATORI GUIDOTTI S.P.A.
    Inventors: Alberto Aleotti, Maria Altamura, Carlo Maggi
  • Publication number: 20070281944
    Abstract: Disclosed are non-peptide compounds having activity as selective antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an amino acid alpha substituted with a cyclic group and by a tetraalkylammonium group. Also disclosed are pharmaceutical compositions containing the compound, and methods of using the compounds to treat patients having conditions, disorders or diseases involving activation of bradykinin B2 receptor.
    Type: Application
    Filed: April 10, 2007
    Publication date: December 6, 2007
    Applicant: ISTITUTO LUSO FARMACO D'ITALIA S.p.A.
    Inventors: Patrizia Felicetti, Christopher Fincham, Alessandro Giolitti, Carlo Maggi, Laura Quartara, Cristina Rossi
  • Publication number: 20060223814
    Abstract: The present invention describes compounds with formula (I) having linear structure basic properties useful as NK-2 antagonists; pharmaceutical compositions containing said compounds are also described and processes for their preparation.
    Type: Application
    Filed: April 23, 2004
    Publication date: October 5, 2006
    Inventors: Daniela Fattori, Marina Porcelloni, Pierro D'Andrea, Cristina Rossi, Maria Altamura, Carlo Maggi
  • Publication number: 20060205712
    Abstract: Non-peptide compounds of formula (I) having activity as specific antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an alpha, alpha-disubstituted amino acid at least one amino group, free or salified, or the corresponding ammonium quaternary salt.
    Type: Application
    Filed: June 5, 2003
    Publication date: September 14, 2006
    Inventors: Federico Calvani, Fernando Catrambone, Patrizia Felicetti, Christopher Fincham, Alessandro Giolitti, Carlo Maggi, Laura Quartara, Cristina Rossi, Rosa Terracciano
  • Patent number: 5366345
    Abstract: A turbine blade, preferably used in the low pressure stages of a steam turbine, is formed from a basic titanium alloy. Near the blade tip, it has a region, including the blade leading edge with a surface of a material which is more resistant to erosion than the basic titanium alloy.This turbine blade should be simple to manufacture and should have a long life even under difficult operating conditions.This is achieved in that the region including the blade leading edge has a protective layer formed by surface treatment of the basic titanium alloy by means of a high-power energy source, such as, in particular, a laser.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: November 22, 1994
    Assignee: Asea Brown Boveri Ltd.
    Inventors: Claus Gerdes, Carlo Maggi
  • Patent number: 5128447
    Abstract: A synthetic peptide corresponding to the following formula:X--Asp--Y--DTrp--Val--DTrp--Z--K--NH.sub.2where:X=H, Arg, DArg, Lys, DLys, Thr, DThrY=Tyr, Trp, DTrp, Ser, MetZ=Trp, DTrpK=Arg, Phe, DTrp, Tyr, Metand pharmaceutically acceptable salts thereof with organic and inorganic acids as competitive antagonists against neurokinin A (NK-2 receptor).
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: July 7, 1992
    Assignee: A. Menarini Industrie Farmaceutiche Riunite S.r.l.
    Inventors: Paolo Rovero, Vittorio Pestellini, Carlo A. Maggi, Riccardo Patacchini, Paolo Santicioli, Sandro Giuliani, Alberto Meli
  • Patent number: 5080905
    Abstract: Use of a 10-amino-5,6-dihydro-11H-dibenzo(b,e)azepine-6,11-dione of formula I ##STR1## where R represents an atom of hydrogen or a lower alkyl group, especially containing from 1 to 5 carbon atoms, as well as of a therapeutically acceptable salt of said compound, to prepare a drug for use in the treatment of urinary incontinence.
    Type: Grant
    Filed: July 12, 1990
    Date of Patent: January 14, 1992
    Assignee: A. Menarini Industrie Farmaceutiche Riunite s.t.l.
    Inventors: Vittorio Pestellini, Carlo A. Maggi, Alberto Meli, Giovanni Viti
  • Patent number: 4657547
    Abstract: An intraocular lens comprising a lens body provided with a supporting haptic part formed by at least two filiform elements fixed to the lens and appropriately oriented, each of said filiform elements presenting a length suitable to be laid in a surgically made, non-perforating incision located on the outer surface of the sclera wall of the eye so as to provide a firm anchorage which eliminates any tendency of the lens body to be displaced from the correct position in exact correspondence with the pupil of the eye.
    Type: Grant
    Filed: April 16, 1986
    Date of Patent: April 14, 1987
    Assignee: Surgivision Limited
    Inventor: Carlo Maggi
  • Patent number: 4503075
    Abstract: The invention comprises: a derivative of 1-alkylamine-3-[4(p-alkyloxy-benzamide)phenoxy]-2-propanol of general formula I: ##STR1## where R.sub.1 is a linear or branched alkyl chain with 1 to 8 carbon atoms included, an alkenyl chain with 2 to 8 carbon atoms included, or an arylalkyl chain with 7 to 10 carbon atoms included, and R is a linear or branched alkyl group with 1 to 8 carbon atoms included;a compound as above, in an optically active form;pharmaceutically acceptable, non toxic salts of the above compounds;synthesis processes for obtaining the above compounds; anda pharmaceutical composition based on a compound as defined above.
    Type: Grant
    Filed: November 12, 1982
    Date of Patent: March 5, 1985
    Assignee: A. Menarini S.A.S.
    Inventors: Vittorio Pestellini, Mario Ghelardoni, Danilo Giannotti, Alessandro Giolitti, Carlo A. Maggi, Stefano Manzini, Guglielmo Grimaldi, Alberto Meli
  • Patent number: 4466425
    Abstract: An operating table for ophthalmic surgery consisting of a base, held at an adequate height from the floor by supporting members, and on which a stretcher is placed which is movable in the longitudinal sense and adjustable in height, one end of which is connected to an adjustable assembly comprising a first device for positioning the patient's head, with the body being on said stretcher, in the position most convenient for carrying out the surgical operation and a second device supporting a mask element provided with an opening in which the eye to be operated on is adapted and on the edge of which the orbital edge of said eye is sealed.
    Type: Grant
    Filed: January 8, 1982
    Date of Patent: August 21, 1984
    Inventor: Carlo Maggi
  • Patent number: 4372958
    Abstract: A new compound 3(4-phenyl-1-piperazinio-1-yl)-1,2-propanediol 3(theophyllin-7-yl)-1-propanesulphonate, possesses antitussive action and is therefore usable in therapy. The compound is obtained by treating 3(theophyllin-7-yl)-1-propanesulphonic acid with 3(4-phenylpiperazin-1-yl)-1,2-propanediol in a suitable solvent.
    Type: Grant
    Filed: June 10, 1981
    Date of Patent: February 8, 1983
    Assignee: A. Menarini S.A.S.
    Inventors: Vittorio Pestellini, Mario Ghelardoni, Danilo Giannotti, Alberto Meli, Carlo A. Maggi